| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.43 | 1e-10 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.98 | 1e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |